Application of Concordance Probability Estimate to Predict Conversion from Mild Cognitive Impairment to Alzheimer's

Xiaoxia Han1, Yilong Zhang2, Yongzhao Shao1

  • 1Department of Population Health, New York University School of Medicine, New York, New York, US.

Insights

Identifying mild cognitive impairment (MCI) patients at high risk for Alzheimer's disease (AD) dementia is crucial. This study introduces the K-index for more accurate prognostic evaluation in MCI to AD progression prediction models.

Area of Science:

  • Neuroscience
  • Gerontology
  • Biostatistics

Background:

  • Mild cognitive impairment (MCI) significantly increases the risk of developing Alzheimer's disease (AD) dementia.
  • Accurate prediction of AD progression in MCI patients is vital for effective clinical management.
  • Existing risk prediction models often rely on accuracy metrics like AUC or Harrell's C-statistic, which have limitations.

Purpose of the Study:

  • To evaluate the prognostic accuracy of a Cox proportional hazards (PH) model for predicting MCI to AD conversion.
  • To introduce and utilize the Gönen & Heller's K-index (concordance probability estimate - CPE) as a robust measure of predictive accuracy.
  • To address limitations of existing metrics by employing a method independent of censoring distribution.

Main Methods:

  • Development of a Cox proportional hazards (PH) model to predict the conversion from MCI to AD.
  • Utilized the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset for model building and validation.
  • Evaluated the prognostic accuracy of the model using the K-index (CPE).

Main Results:

  • A Cox PH model was successfully constructed to predict Alzheimer's disease progression in subjects with mild cognitive impairment.
  • The K-index was employed to assess the overall predictive accuracy of the developed model.
  • The study demonstrated the utility of the K-index in evaluating prognostic models for neurodegenerative disease progression.

Conclusions:

  • The K-index provides a reliable measure for assessing the predictive accuracy of Cox PH models in the context of Alzheimer's disease progression.
  • This approach offers an alternative to AUC and Harrell's C-statistic, particularly in the presence of censoring.
  • Accurate prognostic models are essential for identifying high-risk MCI patients, facilitating timely interventions and clinical trial enrollment.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...